Answers are grounded in this paper and cite their sources.
Early detection of Pseudomonas aeruginosa in cystic fibrosis (CF) patients is crucial, since eradication in a later stage is extremely difficult [1]. Until now, it has been assumed that hydrogen cyanide (HCN) can be considered as a specific biomarker for P. aeruginosa in exhaled breath [2–5]. Only Burkholderia cepacia is also known to produce HCN in vitro [6, 7], but HCN is not a biomarker for B. cepacia complex infection in vivo [8]. To our knowledge, actual proof that HCN is not produced by other pathogens is lacking. Investigations into the emission of HCN by Staphylococcus aureus , a predominant CF pathogen throughout childhood, have been very limited. In a single report, five strains have been shown to produce low values in vitro [9], and in vivo studies have not been reported. Hydrogen cyanide is produced by S. aureus in vitro and in vivo and is not an exclusive biomarker for P. aeruginosa
No takes yet. Share an insight, caveat, or question.
Neerincx et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: